Tel Aviv, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) — OG Global Import is pleased to announce a new partnership with Orta, Tel Aviv’s innovative lifestyle pharmacy, marking a significant step in expanding access to clean, natural, and high-quality indie wellness and beauty brands across Israel. This collaboration reflects OG Global Import’s continued commitment to elevating the retail landscape and supporting the rapid growth of modern wellness consumers.

Orta has quickly become a standout destination for next-generation pharmacy retail, offering personal service, a refined shopping experience, and a vibrant community of wellness-focused customers. Through this partnership, OG Global Import will introduce a curated lineup of international indie brands that align with Orta’s emphasis on transparency, quality, and contemporary wellness standards.
Under the leadership of Co-CEO Ofri Shaysh, OG Global Import has built a strong reputation for responsible market expansion and successful brand integration. This partnership strengthens the company’s position as a trusted operator and highlights its focus on bringing global innovation into fast-growing local categories.
This announcement is part of OG Global Import’s broader initiative to enhance its digital presence, increase positive visibility, and provide the public and industry partners with a clear understanding of the company’s values, professionalism, and ongoing contribution to the beauty and wellness sectors.

Attachments
CONTACT: OG Global Import info@ogglobalimport.com



Đề xuất
Reed Smith LLP Announces Proposed Settlement of In re The Beauty Health Company Consolidated Stockholder Litigation
Dermalogic Laser Center Launches New, Upgraded Website
Toll Brothers Announces New Luxury Home Community, Piney Trail Estates, is Coming Soon to Parker, Colorado
Gymboree and Marchesa Introduce MARCHESA MINI X GYMBOREE, a Collection of Elevated Occasion-Wear
Prepared and Aware: 4 Travel Safety Tips for Your 2026 Getaway
Organic Personal Care Products Market Size to Hit USD 63.63 Billion by 2035 | Research by SNS Insider